Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Clinical trial NCT01033422 · COMPLETED
Trial details
- NCT number
- NCT01033422
- Sponsor
- Can-Fite BioPharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2016-12-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.